Kalkine has a fully transformed New Avatar.

Last update at 2026-03-10T20:00:00Z
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
Meta, Broadcom Lead Five Stocks Forging New Buy Points In Market Pullback
Sat 24 May 25, 12:00 PMAre Medical Stocks Lagging Amedisys (AMED) This Year?
Fri 23 May 25, 01:40 PM2 Cash-Producing Stocks on Our Watchlist and 1 to Avoid
Thu 22 May 25, 04:37 AM5 Broker-Loved Stocks to Watch Amid Signs of Easing Trade Woes
Fri 16 May 25, 02:52 PMBest Momentum Stock to Buy for May 14th
Wed 14 May 25, 11:24 AMNew Strong Buy Stocks for May 14th
Wed 14 May 25, 10:21 AMBrightSpring Health Services' (NASDAQ:BTSG) Strong Earnings Are Of Good Quality
Sat 10 May 25, 12:26 PMIPO Stock Of The Week: Health Care Leader BrightSpring Poised To Hit New Buy Point
Fri 09 May 25, 07:14 PM| Breakdown | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Income before tax | -177.41300M | -45.75400M | 68.86M | 26.24M | -103.57900M |
| Minority interest | 2.23M | 0.31M | -1.46300M | -0.34100M | - |
| Net income | -154.60300M | -53.90700M | 49.80M | 20.81M | -72.38100M |
| Selling general administrative | 1286.61M | 1125.56M | 1014.03M | 883.55M | - |
| Selling and marketing expenses | - | - | - | - | - |
| Gross profit | 1433.79M | 1354.24M | 1248.21M | 1048.74M | 833.91M |
| Reconciled depreciation | 202.34M | 203.97M | 199.16M | 181.50M | - |
| Ebit | 147.18M | 296.03M | 234.18M | 165.19M | 137.55M |
| Ebitda | 349.52M | 500.00M | 433.34M | 346.69M | 292.41M |
| Depreciation and amortization | 202.34M | 203.97M | 199.16M | 181.50M | 154.87M |
| Non operating income net other | - | - | - | - | - |
| Operating income | 147.18M | 296.03M | 234.18M | 273.81M | 137.55M |
| Other operating expenses | 8679.00M | 7424.53M | 6463.90M | 5306.56M | 4387.66M |
| Interest expense | 324.59M | 233.58M | 165.32M | 138.95M | 166.89M |
| Tax provision | -20.57800M | 8.46M | 17.60M | 5.09M | - |
| Interest income | - | - | - | - | - |
| Net interest income | -324.59300M | -233.58400M | -165.32200M | -138.95300M | - |
| Extraordinary items | - | - | - | - | - |
| Non recurring | - | - | - | - | - |
| Other items | - | - | - | - | - |
| Income tax expense | -20.57800M | 8.46M | 17.60M | 5.09M | -32.49100M |
| Total revenue | 8826.17M | 7720.56M | 6698.08M | 5580.37M | 4525.21M |
| Total operating expenses | 1286.61M | 1058.21M | 1014.03M | 774.93M | 696.36M |
| Cost of revenue | 7392.38M | 6366.32M | 5449.87M | 4531.63M | 3691.30M |
| Total other income expense net | -324.59300M | -341.78300M | -165.32200M | -138.95300M | -241.12500M |
| Discontinued operations | - | - | - | - | - |
| Net income from continuing ops | -156.83500M | -54.21900M | 51.26M | 21.15M | - |
| Net income applicable to common shares | - | - | - | - | - |
| Preferred stock and other adjustments | - | - | - | - | - |
| Breakdown | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
| Total assets | 5926.14M | 5532.72M | 5441.14M | 5513.14M | 4541.07M |
| Intangible assets | 811.48M | 881.48M | 975.86M | 1111.55M | 1095.90M |
| Earning assets | - | - | - | - | - |
| Other current assets | 42.15M | 13.19M | 13.51M | 12.66M | 16.41M |
| Total liab | 4274.56M | 4920.17M | 4657.06M | 4712.68M | 3805.70M |
| Total stockholder equity | 1647.86M | 584.74M | 754.78M | 774.82M | 704.98M |
| Deferred long term liab | - | - | - | - | - |
| Other current liab | 335.21M | - | - | - | - |
| Common stock | 1.74M | - | - | - | - |
| Capital stock | 1.74M | 1.18M | 1.18M | 1.18M | 745.17M |
| Retained earnings | -222.15500M | -200.31900M | -45.71600M | 0.97M | -51.75200M |
| Other liab | - | - | - | - | - |
| Good will | 2671.52M | 2608.41M | 2576.08M | 2657.89M | 1669.39M |
| Other assets | - | - | - | - | - |
| Cash | 61.25M | 13.07M | 13.63M | 46.73M | 262.00M |
| Cash and equivalents | - | - | - | - | - |
| Total current liabilities | 1428.33M | 1248.44M | 932.51M | 892.16M | 742.79M |
| Current deferred revenue | 11.00M | - | - | - | - |
| Net debt | 2843.71M | 3351.14M | 3381.08M | 3387.04M | 2431.84M |
| Short term debt | 130.50M | - | - | - | - |
| Short long term debt | 48.73M | 32.27M | 30.41M | 40.54M | 22.50M |
| Short long term debt total | 2904.97M | - | - | - | - |
| Other stockholder equity | 1866.85M | - | - | - | - |
| Property plant equipment | - | - | - | - | - |
| Total current assets | 1893.05M | 1456.64M | 1344.26M | 1180.61M | 1290.38M |
| Long term investments | 0.67M | 0.72M | 0.74M | 2.66M | 2.48M |
| Net tangible assets | - | - | - | - | - |
| Short term investments | - | - | - | - | - |
| Net receivables | 1149.08M | 881.63M | 775.84M | 730.27M | 625.63M |
| Long term debt | 2561.86M | 3331.94M | 3364.30M | 3393.24M | 2671.34M |
| Inventory | 640.57M | 402.78M | 430.52M | 299.22M | 300.06M |
| Accounts payable | 941.29M | 641.61M | 526.92M | 408.11M | 355.75M |
| Total permanent equity | - | - | - | - | - |
| Noncontrolling interest in consolidated entity | - | - | - | - | - |
| Temporary equity redeemable noncontrolling interests | - | - | - | - | - |
| Accumulated other comprehensive income | 1.42M | - | - | - | - |
| Additional paid in capital | - | - | - | - | - |
| Common stock total equity | - | - | - | - | - |
| Preferred stock total equity | - | - | - | - | - |
| Retained earnings total equity | - | - | - | - | - |
| Treasury stock | - | - | - | - | - |
| Accumulated amortization | - | - | - | - | - |
| Non currrent assets other | 43.80M | 16.49M | 14.29M | 12.12M | 11.25M |
| Deferred long term asset charges | - | - | - | - | - |
| Non current assets total | 4033.09M | 4076.08M | 4096.88M | 4332.53M | 3250.69M |
| Capital lease obligations | 294.38M | 306.38M | 282.36M | 336.77M | 280.46M |
| Long term debt total | - | - | - | - | - |
| Breakdown | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Investments | -134.43300M | 45.36M | -1190.65200M | -452.86700M | - |
| Change to liabilities | - | - | - | - | - |
| Total cashflows from investing activities | - | - | - | - | - |
| Net borrowings | - | - | - | - | - |
| Total cash from financing activities | -76.90700M | -73.81000M | 705.22M | 472.92M | 1409.08M |
| Change to operating activities | - | - | - | - | - |
| Net income | -154.60300M | -53.90700M | 51.26M | 20.81M | -72.38100M |
| Change in cash | -0.55700M | -248.37700M | -215.27000M | 243.71M | -12.22900M |
| Begin period cash flow | 13.63M | 262.00M | 262.00M | 18.30M | 30.52M |
| End period cash flow | 13.07M | 13.63M | 46.73M | 262.00M | 18.30M |
| Total cash from operating activities | 210.78M | -4.65300M | 270.17M | 222.64M | 110.91M |
| Issuance of capital stock | 0.00000M | 0.00000M | 12.80M | 0.00000M | - |
| Depreciation | 202.34M | 203.97M | 199.16M | 181.50M | 154.87M |
| Other cashflows from investing activities | - | - | - | - | - |
| Dividends paid | - | - | - | - | - |
| Change to inventory | 28.66M | -131.83300M | 4.29M | -95.73000M | -16.03200M |
| Change to account receivables | -127.24600M | -150.46600M | -93.00300M | -58.91500M | -53.94500M |
| Sale purchase of stock | -10.65000M | 0.00000M | -0.41700M | -1.12400M | -12.29000M |
| Other cashflows from financing activities | -10.12000M | -4.88000M | -34.02900M | -3.83200M | -14.59200M |
| Change to netincome | - | - | - | - | - |
| Capital expenditures | 73.53M | 70.11M | 59.27M | 51.91M | 51.22M |
| Change receivables | - | - | - | - | - |
| Cash flows other operating | - | - | - | - | - |
| Exchange rate changes | - | - | - | - | - |
| Cash and cash equivalents changes | - | - | - | - | - |
| Change in working capital | 159.44M | -224.46500M | -30.10700M | -36.08300M | -6.47700M |
| Stock based compensation | 3.92M | 3.55M | 4.52M | 6.27M | 3.71M |
| Other non cash items | 52.33M | 654.48M | 21.20M | 451.03M | 402.25M |
| Free cash flow | 137.26M | -74.76600M | 210.90M | 170.73M | 59.69M |
Sector: Healthcare Industry: Health Information Services
| Company | Change (USD) | Price (USD) | Trailing PE (x) | Forward PE (x) | Price Sales TTM (x) | Price to Book Value (x) | Enterprise Value to Revenue (x) | Enterprise Value to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| BTSG BrightSpring Health Services, Inc. Common Stock |
-0.89 2.11% | 41.34 | 90.48 | 42.19 | 0.36 | 2.52 | 0.58 | 14.72 |
| GEHC GE HealthCare Technologies Inc. |
-2.9 3.83% | 72.73 | 22.91 | 20.12 | 2.01 | 5.52 | 2.39 | 13.30 |
| VEEV Veeva Systems Inc Class A |
-5.88 3.01% | 189.69 | 54.61 | 33.22 | 12.83 | 6.73 | 11.14 | 58.84 |
| MTHRF M3 Inc |
- -% | 11.42 | 29.72 | 25.00 | 0.05 | 4.38 | 0.04 | 0.12 |
| MTHRY M3 Inc |
-0.07 1.34% | 5.17 | 31.84 | 26.25 | 0.05 | 4.60 | 0.04 | 0.12 |
BrightSpring Health Services, Inc. operates as a home and community-based healthcare services platform in the United States. It operates through two segments, Pharmacy Solutions and Provider Services. The company's platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations. It also offers infused, injectable, and oral medication services; and patient-centric, highly skilled, and compassionate clinical home health care, as well as rehabilitation services, including physical, speech and occupational therapy and applied behavioral analysis. The company was formerly known as Phoenix Parent Holdings Inc. and changed its name to BrightSpring Health Services, Inc. in May 2021. BrightSpring Health Services, Inc. was founded in 1974 and is headquartered in Louisville, Kentucky.
805 North Whittington Parkway, Louisville, KY, United States, 40222
| Name | Title | Year Born |
|---|---|---|
| Mr. Jon B. Rousseau | Chairman, President & CEO | 1974 |
| Mr. Jim Mattingly Jr. | Executive VP & CFO | 1979 |
| Mr. Steven Spencer Reed Esq. | Corporate Secretary & Chief Legal Officer | 1962 |
| Mr. Robert A. Barnes | President of Community Living | 1972 |
| Ms. Jennifer Yowler | President of PharMerica | 1977 |
| Ms. Jennifer A. Phipps | Chief Accounting Officer | NA |
| Mr. Phani Konduru | Chief Digital & Technology Officer | NA |
| Ms. Rachael Kurzer Givens | Chief Compliance Officer | NA |
| Ms. Lisa Nalley | Chief of Staff & Senior VP of Human Resources | 1975 |
| Mr. Mike McMaude | President of Home Health & Hospice Services | 1969 |
Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.